ARC vs ADVM Comparison

ARC Document Solutions Inc is a world-wide document solutions provider. The company's service offerings include Digital Printing, managed print services (MPS), Scanning and Digital Imaging, archive and Equipment and Supplies Sales, Web-based document management applications, and equipment and supplies sales. Its product application involves in several industries such as the architectural, engineering, and construction. It principally engages in providing an onsite service to install a complete document solution platform in its customers' offices and project sites operate offsite service centers and enable its customers to store information and intellectual property in a cloud-based and searchable digital archive.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.